DE602004022506D1 - Bakteriophage zur behandlung von bakteriellen biofilmen - Google Patents
Bakteriophage zur behandlung von bakteriellen biofilmenInfo
- Publication number
- DE602004022506D1 DE602004022506D1 DE602004022506T DE602004022506T DE602004022506D1 DE 602004022506 D1 DE602004022506 D1 DE 602004022506D1 DE 602004022506 T DE602004022506 T DE 602004022506T DE 602004022506 T DE602004022506 T DE 602004022506T DE 602004022506 D1 DE602004022506 D1 DE 602004022506D1
- Authority
- DE
- Germany
- Prior art keywords
- bacteriophage
- treatment
- biofilm
- bacteriophages
- bacterial biofilms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001515965 unidentified phage Species 0.000 title abstract 6
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 241000894006 Bacteria Species 0.000 abstract 1
- 102000016911 Deoxyribonucleases Human genes 0.000 abstract 1
- 108010053770 Deoxyribonucleases Proteins 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000000593 degrading effect Effects 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 102000020244 polysaccharide lyase Human genes 0.000 abstract 1
- 108091022901 polysaccharide lyase Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
- C12Y402/02003—Poly(beta-D-mannuronate) lyase (4.2.2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10041—Use of virus, viral particle or viral elements as a vector
- C12N2795/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0300597.2A GB0300597D0 (en) | 2003-01-10 | 2003-01-10 | Phage biofilms |
PCT/GB2004/000073 WO2004062677A1 (en) | 2003-01-10 | 2004-01-12 | Bacteriophage for the treatment of bacterial biofilms |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004022506D1 true DE602004022506D1 (de) | 2009-09-24 |
Family
ID=9950965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004022506T Expired - Lifetime DE602004022506D1 (de) | 2003-01-10 | 2004-01-12 | Bakteriophage zur behandlung von bakteriellen biofilmen |
Country Status (6)
Country | Link |
---|---|
US (1) | US7758856B2 (de) |
EP (1) | EP1587520B1 (de) |
AT (1) | ATE439139T1 (de) |
DE (1) | DE602004022506D1 (de) |
GB (1) | GB0300597D0 (de) |
WO (1) | WO2004062677A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2570130B1 (de) | 2003-07-23 | 2014-11-26 | Biocontrol Limited | Bakteriophagen gegen P. aeruginosa enhaltende therapeutische Wirkstoffe |
CA2578478A1 (en) * | 2004-08-06 | 2006-02-16 | National Jewish Medical And Research Center | Product and process for inhibition of biofilm development |
WO2006137847A2 (en) * | 2004-09-13 | 2006-12-28 | Trustees Of Boston University | Engineered enzymatically active bacteriophages and methods of uses thereof |
WO2006095345A2 (en) | 2005-03-08 | 2006-09-14 | Ramot At Tel-Aviv University Ltd. | Targeted drug-carrying bacteriophages |
US7932029B1 (en) * | 2006-01-04 | 2011-04-26 | Si Lok | Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities |
US8178087B2 (en) | 2006-04-04 | 2012-05-15 | Centre National de la Recherche Scientifique —CNRS | Process of production of bacteriophage compositions and methods in phage therapy field |
KR100781669B1 (ko) | 2006-06-20 | 2007-12-03 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균 특이적 사멸능을 갖는 박테리오파지 |
KR100759988B1 (ko) | 2006-08-04 | 2007-09-19 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균에 특이적인 항균 단백질 |
GB0704553D0 (en) * | 2007-03-09 | 2007-04-18 | Harper David R | Beneficial effects of bacteriophage treatments |
US7622293B2 (en) * | 2007-06-18 | 2009-11-24 | Intralytix, Inc. | Pseudomonas aeruginosa: bacteriophage and uses thereof |
US8366652B2 (en) * | 2007-08-17 | 2013-02-05 | The Invention Science Fund I, Llc | Systems, devices, and methods including infection-fighting and monitoring shunts |
US8734718B2 (en) | 2007-08-17 | 2014-05-27 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component |
KR100910961B1 (ko) | 2007-09-13 | 2009-08-05 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질 |
DK2268142T3 (en) | 2007-11-27 | 2017-05-22 | Algipharma As | USING ALGINATED OLIGOMERS TO FIGHT BIOFILM |
US8153119B2 (en) * | 2007-12-18 | 2012-04-10 | Trustees Of Boston University | Engineered enzymatically active bacteriophage and methods for dispersing biofilms |
US8329889B2 (en) * | 2008-02-15 | 2012-12-11 | Trustees Of Boston University | In vivo gene sensors |
US8889105B2 (en) * | 2008-11-28 | 2014-11-18 | Warren H. Finlay | Bacteriophage compositions for treatment of bacterial infections |
EP2384168B1 (de) | 2008-12-04 | 2014-10-08 | Searete LLC | Aktiv kontrollierbare sterilisierende erregungsabgabe-implantate |
US20110208021A1 (en) * | 2008-12-04 | 2011-08-25 | Goodall Eleanor V | Systems, devices, and methods including implantable devices with anti-microbial properties |
US20120041287A1 (en) * | 2008-12-04 | 2012-02-16 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems, devices, and methods including implantable devices with anti-microbial properties |
US20110160681A1 (en) * | 2008-12-04 | 2011-06-30 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems, devices, and methods including catheters having light removable coatings based on a sensed condition |
US20110208026A1 (en) * | 2008-12-04 | 2011-08-25 | Goodall Eleanor V | Systems, devices, and methods including implantable devices with anti-microbial properties |
US8043613B2 (en) | 2009-02-12 | 2011-10-25 | Intron Biotechnology, Inc. | Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus |
US8377866B2 (en) | 2009-02-12 | 2013-02-19 | Intron Biotechnology, Inc. | Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus |
WO2010141135A2 (en) | 2009-03-05 | 2010-12-09 | Trustees Of Boston University | Bacteriophages expressing antimicrobial peptides and uses thereof |
CN102458474B (zh) | 2009-06-03 | 2014-06-11 | 阿尔吉法玛公司 | 使用藻酸盐低聚物和抗生素治疗不动杆菌 |
EP2473042B1 (de) * | 2009-09-02 | 2017-08-02 | Synedgen, Inc. | Verfahren und zusammensetzungen zur zersetzung eines biofilms mithilfe von chitosanderivat-komponenten |
CN103732235B (zh) * | 2010-09-17 | 2018-01-02 | 药物技术业制药技术股份有限公司 | 抗菌噬菌体、噬菌体肽及其使用方法 |
EP2465926A1 (de) * | 2010-12-20 | 2012-06-20 | University College Cork | Pseudomonas aeruginosa-Bakteriophage und Verwendungen davon |
US20140221308A1 (en) * | 2011-07-01 | 2014-08-07 | Synedgen, Inc. | Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds |
US8669226B2 (en) | 2011-10-07 | 2014-03-11 | Morehouse School Of Medicine | Antimicrobial compositions and methods of use thereof |
WO2014059313A1 (en) | 2012-10-12 | 2014-04-17 | Lehigh University | Thermally stable enzymes, compositions thereof and methods of using same |
DE102013106455A1 (de) * | 2013-06-20 | 2014-12-24 | Airbus Defence and Space GmbH | Verfahren zur Dekontamination von bakteriologischen Verunreinigungen |
JP2017524344A (ja) | 2014-06-06 | 2017-08-31 | ザ・ホスピタル・フォー・シック・チルドレンThe Hospital For Sick Children | バイオフィルムの阻害及び分散における可溶性細菌及び真菌タンパク質並びに方法並びにそれらの使用 |
CA2960998A1 (en) | 2014-09-11 | 2016-03-17 | Synedgen, Inc. | Compositions and methods of use thereof |
US11185555B2 (en) | 2016-04-11 | 2021-11-30 | Noah James Harrison | Method to kill pathogenic microbes in a patient |
CA3026590A1 (fr) | 2016-06-08 | 2017-12-14 | Onelife S.A. | Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implantation infections |
CN112543595B (zh) | 2018-05-30 | 2022-11-01 | 莫尔豪斯医学院 | 抗微生物组合物,其制备方法和用途 |
EP4380586A1 (de) * | 2021-08-02 | 2024-06-12 | Armata Pharmaceuticals, Inc. | Bakteriophagen mit verbesserter antimikrobieller wirkung |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678750A (en) * | 1984-10-18 | 1987-07-07 | Microlife Technics, Inc. | Method and compositions for use in the treatment of fireblight |
US5032574A (en) | 1988-05-26 | 1991-07-16 | Invitron Corporation | Novel antimicrobial peptide |
US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
WO1993024513A1 (en) * | 1992-05-22 | 1993-12-09 | The Children's Hospital Of Philadelphia | Gastrointestinal defensins, cdna sequences and method for the production and use thereof |
DE69324918T2 (de) * | 1993-02-24 | 1999-11-11 | Gunze Kk | Arznei gegen cystische fibrosen |
US5459235A (en) | 1993-03-19 | 1995-10-17 | The Regents Of The University Of California | Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils |
US5550109A (en) | 1994-05-24 | 1996-08-27 | Magainin Pharmaceuticals Inc. | Inducible defensin peptide from mammalian epithelia |
WO1997039111A1 (en) * | 1996-04-15 | 1997-10-23 | Nymox Corporation | Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
US20020037260A1 (en) * | 1997-10-16 | 2002-03-28 | Budny John A. | Compositions for treating biofilm |
EP0925756B8 (de) * | 1997-12-25 | 2008-08-13 | Nihon Kohden Corporation | Gerät zur Übertragung von biologischen Signalen |
ES2252263T3 (es) | 2000-07-25 | 2006-05-16 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Bacteriofago que tiene una gama de hospedadores multiple. |
-
2003
- 2003-01-10 GB GBGB0300597.2A patent/GB0300597D0/en not_active Ceased
-
2004
- 2004-01-12 EP EP04701383A patent/EP1587520B1/de not_active Expired - Lifetime
- 2004-01-12 WO PCT/GB2004/000073 patent/WO2004062677A1/en active Application Filing
- 2004-01-12 AT AT04701383T patent/ATE439139T1/de not_active IP Right Cessation
- 2004-01-12 US US10/541,716 patent/US7758856B2/en active Active
- 2004-01-12 DE DE602004022506T patent/DE602004022506D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004062677A9 (en) | 2004-10-07 |
WO2004062677A1 (en) | 2004-07-29 |
EP1587520B1 (de) | 2009-08-12 |
EP1587520A1 (de) | 2005-10-26 |
GB0300597D0 (en) | 2003-02-12 |
US20060140911A1 (en) | 2006-06-29 |
US7758856B2 (en) | 2010-07-20 |
ATE439139T1 (de) | 2009-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE439139T1 (de) | Bakteriophage zur behandlung von bakteriellen biofilmen | |
ATE534372T1 (de) | Verfahren und zusammensetzungen zur behandlung und prävention von infektionen | |
ATE513551T1 (de) | Zusammensetzungen und verfahren zur wiederherstellung der bakterienflora | |
IL157041A0 (en) | Monoclonal antibodies to the clfa protein and method of use in treating and preventing infections | |
DE60113851D1 (de) | Bakteriophage mit breitem wirtspektrum | |
ATE481134T1 (de) | Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen | |
NO20080338L (no) | Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner | |
DK1663168T3 (da) | Nikotinformuleringer og anvendelse deraf | |
ATE448775T1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
WO2007130655A3 (en) | Phage derived antimicrobial activities | |
NO20083245L (no) | Sykliske antimikrobielle peptider | |
UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
NZ595252A (en) | Biofilm treatment | |
DE602005013648D1 (de) | Behandlung von bakteriellen infektionen | |
WO2005000878A3 (en) | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
DK1675603T3 (da) | Anvendelse af probiotiske bakterier i behandling af infektion | |
EA200600374A1 (ru) | Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью | |
MX2022006109A (es) | Derivados 1-aminosulfonil-2-carboxipirrol como inhibidores de metalo-beta-lactamasa. | |
ATE296536T1 (de) | Nichttoxische beschichtungszusammensetzung, verwendungsverfahren und gegen die anlagerung von biofouling-organismen behandelte gegenstände | |
RS52511B (en) | MACHINE DISINFECTION OF ITEMS | |
DE602004028574D1 (de) | Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie | |
ATE359816T1 (de) | Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren | |
MY128739A (en) | Compositions and methods for treating bacterial infections | |
WO2003061704A3 (en) | Combination therapy for the treatment of bacterial infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |